SANTA CRUZ DE TENERIFE, June 8 (EUROPA PRESS) –
The Government Council of the Canary Islands authorized this Thursday the Ministry of Health to spend 23,122,916 euros for the extension of the framework agreements for the supply of medicines for human use that contain the active ingredients bevacizumab, etanercept and infliximab .
Specifically, the validity of the framework agreements resulting from the contracting file (nº 23/S/20/SU/DG/A/AM25), awarded by the General Directorate of Economic Resources of the Canary Islands Health Service on 23 February, will be extended. July 2021.
In this way, the continuity of the supply of these medicines to the network of hospitals of the Canary Islands Health Service is guaranteed, for a period of two years, between the months of September 2023 and 2025.
